Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated And Eligible To Enroll Patients In ARCHER, A Phase II Trial Of CardiolRx For Treatment Of Acute Myocarditis
Author: Benzinga Newsdesk | September 19, 2023 07:29am